A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2011
10/26/2011	CN1922313B Acid alpha-glucosidase and fragments thereof
10/26/2011	CN102227443A Therapeutic ribonucleases
10/26/2011	CN102227213A Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
10/26/2011	CN102226186A Activated Bax gene for treating malignant tumor by taking adenovirus as carrier
10/26/2011	CN102225968A Recombinant anguilla marmorata follicle stimulating hormone FSH beta alpha and preparation method and application thereof
10/26/2011	CN102225965A Substituted tetrahydro-isoquinoline-3-carboxylic acid compound, preparation method and application thereof
10/26/2011	CN102225964A Self-assembling peptide amphiphiles and related methods for growth factor delivery
10/26/2011	CN102225206A Composite for enhancing transdermal administration and application thereof
10/26/2011	CN102225203A Pharmaceutical composition used for lowering blood pressure
10/26/2011	CN102225200A Methods and compositions for modulating TWEAK and FN14 activity
10/26/2011	CN102225198A Anti-tumour medicine composition and preparation method and application thereof
10/26/2011	CN102225197A Application and extraction method of acrosin
10/26/2011	CN102225196A Application of superoxide dismutase in preparing drugs for treating diseases of cervical erosion and colpitis
10/26/2011	CN102225195A Porcine interferon-gamma composite medicament and application thereof
10/26/2011	CN102225194A Use of Bv8 and/or EG-VEGF to promote hematopoiesis
10/26/2011	CN101838311B Mimic short peptide 7B of endothelial cell growth factor VEGF antigen epitope and application thereof
10/26/2011	CN101822819B Application of pumpkin protein to preparation of medicament for treating gastric cancer
10/26/2011	CN101664543B Hemokinin-iron oral liquid
10/26/2011	CN101589761B Preparation method and application of industrial hemp seed antioxidant peptide
10/26/2011	CN101543624B Purpose of Chilobrachys jingzhao toxin extract-jingzhao toxin-V(JZTX-V) in preparation of drug-breaking medicament
10/26/2011	CN101525598B Method for purifying human urinary trypsin inhibitor
10/26/2011	CN101450214B Transferrin-frog-egg ribonuclease coupler and production method and use thereof
10/26/2011	CN101433712B Liver perfusate and preparation method thereof
10/26/2011	CN101347613B Composition of glucoprotein containing nearly no subunit and preparation method thereof
10/26/2011	CN101108895B Polyglycol ethanal derivant and combo of medicament and the same
10/26/2011	CN101063112B Nucleoside diphosphokinase A oxidation-reduction isomer
10/25/2011	US8044195 Cross-linked glycopeptide-cephalosporin antibiotics
10/25/2011	US8044183 Process for the production of immunogenic compositions
10/25/2011	US8044182 Adiponectin and uses thereof
10/25/2011	US8044176 Carbon nanotube binding peptides
10/25/2011	US8044175 Peptides that specifically bind HGF receptor (CMET) and uses thereof
10/25/2011	US8044174 Thrombopoietic compounds
10/25/2011	US8044103 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
10/25/2011	US8044099 conjugates of a drug moiety and a pharmacokinetic modulating moiety, they exhibit at least one modulated pharmacokinetic property such as half-life, hepatic first-pass metabolism, volume of distribution and degree of blood protein binding, upon administering to a host
10/25/2011	US8044028 Oligopeptides and their use in cosmetics
10/25/2011	US8044027 Utilization of peptides as active ingredients for slimming
10/25/2011	US8044026 Composition for promoting cartilage formation or repair comprising a NELL gene product and method of treating cartilage-related conditions using such composition
10/25/2011	US8044025 Urocortin proteins and uses thereof
10/25/2011	US8044024 Identifying modulators of fibroblast growth factor-like polypeptides
10/25/2011	US8044023 Hepatitis C virus inhibitors
10/25/2011	US8044022 Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
10/25/2011	US8044021 Sustained release of apo A-I mimetic peptides and methods of treatment
10/25/2011	US8044020 Pharmaceutical compositions and methods for insulin treatment
10/25/2011	US8044019 Cell penetrating peptide
10/25/2011	US8044018 Reagents and methods for smooth muscle therapies
10/25/2011	US8044017 Ion exchange chromatography; gradient wash; resolution; remove impurities
10/25/2011	US8043855 vector contains an adenoviral genome from which the open reading frames E1 and/or E3 have been deleted, but retains enough sequence to make it able to replicate in vitro; also contains a DNA sequence regulated by promoters that encode for fibrosis treatment proteins
10/25/2011	US8043831 Therapeutic agents comprising pro-apoptotic proteins
10/25/2011	US8043818 Proteolytic enzyme for use as tool in identifying modulators for prevention and treatment of cell proliferative and immune disorders
10/25/2011	US8043806 Method of diagnosing an RTK-hyperfunction induced disorder
10/25/2011	US8043630 Shell-and-core dosage form approaching zero-order drug release
10/25/2011	US8043629 Bioabsorbable synthetic nonwoven fabric holding thrombin
10/25/2011	US8043628 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides
10/25/2011	US8043612 Infection and treatment of neoplasms with vesicular stomatitis virus
10/25/2011	US8043608 Methods of using Fc-cytokine fusion proteins
10/25/2011	CA2712304C Recombinant chimeric proteins and methods of use thereof
10/25/2011	CA2437983C Transporters comprising spaced arginine moieties
10/25/2011	CA2415923C Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
10/25/2011	CA2399865C Novel scavenger receptor
10/25/2011	CA2395499C Chlamydia antigens and corresponding dna fragments and uses thereof
10/25/2011	CA2341568C Stabilized pharmaceutical composition in lyophilized form
10/25/2011	CA2330131C Method for the treatment of fertility disorders
10/20/2011	WO2011130745A1 Compositions and methods for treating copd exacerbation
10/20/2011	WO2011130729A2 Methods for treating metabolic disorders using fgf
10/20/2011	WO2011130686A2 Promoting erythropoietin, erythrocyte, and hematopoietic stem cell production by activating hif in osteoblasts
10/20/2011	WO2011130662A1 Methods and related kits for treating and regenerating tooth pulp and periapical tissues in a mammal
10/20/2011	WO2011130618A2 Compositions and methods for producing glycosylated human pdx-1 protein and methods of use therefore
10/20/2011	WO2011130552A2 Serca2 therapeutic compositions and methods of use
10/20/2011	WO2011130537A2 Pharmaceutical compositions and methods for digesting atherosclerotic plaques
10/20/2011	WO2011130479A2 Application of polymeric materials to screens to facilitate hemostasis and wound healing
10/20/2011	WO2011130425A1 Method to detect endothelial cell massive calcium accumulation death
10/20/2011	WO2011130354A1 Fibronectin based scaffold domain proteins that bind pcsk9
10/20/2011	WO2011130347A2 Methods for enhancing axonal regeneration
10/20/2011	WO2011130145A1 Banana lectins and uses thereof
10/20/2011	WO2011128884A1 Extract and peptides derived from oryza sativa japonica group and uses thereof
10/20/2011	WO2011128701A2 Cancer methods
10/20/2011	WO2011128631A2 Vegetarian oral pharmaceutical and nutraceutical compositions
10/20/2011	WO2011128561A1 Robo1-fc fusion protein and use thereof for treating tumours
10/20/2011	WO2011128444A2 Capping-prone rna polymerase enzymes and their applications
10/20/2011	WO2011127624A1 Anti-hiv peptide
10/20/2011	WO2011127519A1 Combination treatment with vegf-c antagonists
10/20/2011	WO2011100700A3 Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies
10/20/2011	WO2011093932A3 Design of fibrinogen and fibrinogen derived products with reduced bacterial binding by using modified sequences of fibrinogen chains
10/20/2011	WO2011084685A3 Saposin-a derived peptides and uses thereof
10/20/2011	WO2011080739A3 Synergistic antibiotic combinations and derivatives
10/20/2011	WO2011072247A8 Pathogen restriction factors
10/20/2011	WO2011066521A3 Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
10/20/2011	WO2011066374A3 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
10/20/2011	WO2011066372A3 Citrullination of human peptidylarginine deiminase 4 (pad-4) regulates its function and immunogenicity
10/20/2011	WO2011066371A3 Antibodies to il-6 and use thereof
10/20/2011	WO2011063394A3 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
10/20/2011	WO2011063263A3 Methods for producing an immune response to tuberculosis
10/20/2011	WO2011044443A3 Matricryptic ecm peptides for tissue reconstruction
10/20/2011	WO2011036297A3 Method for the therapy and diagnosis of alzheimer's disease
10/20/2011	WO2011016840A3 Methods and compositions for treating trinucleotide repeat disorders
10/20/2011	US20110258713 Compositions and methods for re-programming cells without genetic modification
10/20/2011	US20110258712 Myostatin isoform
10/20/2011	US20110257601 Vegf antagonist formulations for intravitreal administration
10/20/2011	US20110257504 Biologically integrated electrode devices
10/20/2011	US20110257460 Capturing and delivering molecules in a mammal

1 ... 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 ... 3163